Full notification file
Member State to which the notification was sent
Date of acknowledgement from the Member State Competent Authority
Title of the Project
Treatment of Advanced Gastrointestinal Adenocarcinoma in a Phase I/II trial with modified allogeneic MSC_apceth_111
Proposed period of release:
01/10/2015 to 31/12/2016
Name of the Institute(s) or Company(ies)
apceth GmbH & Co.KG, ;
3. Is the same GMO release planned elsewhere in the Community?
Has the same GMO been notified elsewhere by the same notifier?
GMO is a:
Identity of the GMO:
Identity of the GMO (genus and species)
Genetically modified mesenchymal stem cells (somatic cells) derived from Homo sapiens.
Information relating to the recipient or parental organisms from wich the GMO is derived
Mesenchymal stem cell derived from humans
European Commission administrative information
Consent given by the Member State Competent Authority: